First Time Loading...

Maravai LifeSciences Holdings Inc
NASDAQ:MRVI

Watchlist Manager
Maravai LifeSciences Holdings Inc Logo
Maravai LifeSciences Holdings Inc
NASDAQ:MRVI
Watchlist
Price: 8.75 USD -2.34% Market Closed
Updated: May 8, 2024
Section:
 

Relative Value

The Relative Value of one MRVI stock under the Base Case scenario is 6.44 USD. Compared to the current market price of 8.75 USD, Maravai LifeSciences Holdings Inc is Overvalued by 26%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

MRVI Relative Value
Base Case
6.44 USD
Overvaluation 26%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

7.6
P/S
P/S
Price to Sales
7.6
vs History
29
vs Industry
25
Median 3Y
6
Median 5Y
5.7
Industry
3.9
Forward
7.9
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
4
Median 3Y
27.4
Median 5Y
22.6
Industry
31.1
Forward
-471.7
More Details
17.4
P/OCF
P/OCF
Price to OCF
17.4
vs History
36
vs Industry
35
Median 3Y
15.1
Median 5Y
15.2
Industry
23.3
More Details
33.9
P/FCFE
P/FCFE
Price to FCFE
33.9
vs History
0
vs Industry
20
Median 3Y
19.9
Median 5Y
20.4
Industry
27.4
More Details
5.3
P/B
P/B
Price to Book Value
5.3
vs History
72
vs Industry
16
Median 3Y
8.3
Median 5Y
12.3
Industry
2.5
More Details
7.5
EV/S
EV/S
Enterprise Value to Sales
7.5
vs History
29
vs Industry
23
Median 3Y
5.9
Median 5Y
5.7
Industry
3.8
Forward
7.8
More Details
15.5
EV/GP
EV/GP
Enterprise Value to Gross Profit
15.5
vs History
15
vs Industry
20
Median 3Y
9.5
Median 5Y
8.3
Industry
7.9
More Details
144.3
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
144.3
vs History
13
vs Industry
3
Median 3Y
13.5
Median 5Y
13.8
Industry
17.2
Forward
34.3
More Details
Negative
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
N/A
vs History
vs Industry
26
Median 3Y
10.4
Median 5Y
8.3
Industry
22.7
Forward
134.9
More Details
17.2
EV/OCF
EV/OCF
Enterprise Value to OCF
17.2
vs History
36
vs Industry
37
Median 3Y
14.9
Median 5Y
15.1
Industry
21.4
More Details
35.8
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
35.8
vs History
15
vs Industry
20
Median 3Y
17
Median 5Y
18
Industry
27.9
More Details
2.4
EV/IC
EV/IC
Enterprise Value to IC
2.4
vs History
54
vs Industry
43
Median 3Y
2.5
Median 5Y
3.6
Industry
2.4
More Details

Multiples Across Competitors

MRVI Competitors Multiples
Maravai LifeSciences Holdings Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Maravai LifeSciences Holdings Inc
NASDAQ:MRVI
2.2B USD 7.6 -18.5 144.3 -86.4
US
Thermo Fisher Scientific Inc
NYSE:TMO
221.9B USD 5.2 37 22.9 33.5
US
Danaher Corp
NYSE:DHR
184.1B USD 4.2 22.8 16.6 20.5
US
Agilent Technologies Inc
NYSE:A
41.7B USD 6.2 33.7 26.9 32.4
CH
Lonza Group AG
SIX:LONN
37.7B CHF 5.6 57.7 19.8 29.1
KR
Samsung Biologics Co Ltd
KRX:207940
56.3T KRW 15.2 65.6 34.6 49.8
US
IQVIA Holdings Inc
NYSE:IQV
41.3B USD 2.8 30.4 16.6 25.6
US
Mettler-Toledo International Inc
NYSE:MTD
27.1B USD 7.2 34.4 24 26.7
US
West Pharmaceutical Services Inc
NYSE:WST
26.6B USD 9.1 46.8 32.5 39.5
IE
ICON PLC
NASDAQ:ICLR
25.6B USD 3.1 37.5 16.9 26
FR
Sartorius Stedim Biotech SA
PAR:DIM
18.8B EUR 6.9 74 31.9 52.3

See Also

Summary
MRVI intrinsic value, competitors valuation, and company profile.
DCF Valuation
MRVI stock valuation using Discount Cash Flow valuation method.
Relative Valuation
MRVI stock valuation using valuation multiples.
Wall Street Estimates
MRVI price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
MRVI stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 135,400+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.